
As Asian markets navigate a landscape marked by fluctuating technology stocks and geopolitical tensions, investors are increasingly looking for companies that demonstrate robust growth potential and stability. In this context, growth companies with high insider ownership and impressive revenue expansion, such as those achieving 18 percent revenue growth, can offer compelling opportunities due to their alignment of interests between management and shareholders.
| Name | Insider Ownership | Earnings Growth |
| Zhejiang Taotao Vehicles (SZSE:301345) | 27.9% | 31.5% |
| Shanghai Biren Technology (SEHK:6082) | 11% | 116.9% |
| SEERS (KOSDAQ:A458870) | 33.2% | 41.5% |
| Meitu (SEHK:1357) | 22.8% | 31.3% |
| Meiko Electronics (TSE:6787) | 19.2% | 28.0% |
| Jiangxi Fushine Pharmaceutical (SZSE:300497) | 21.1% | 55.9% |
| HUMAN MADE (TSE:456A) | 23.9% | 23.4% |
| Gold Circuit Electronics (TWSE:2368) | 30.1% | 38.2% |
| Fulin Precision (SZSE:300432) | 10.4% | 60.7% |
| Biocytogen Pharmaceuticals (Beijing) (SEHK:2315) | 14.1% | 40.4% |
We'll examine a selection from our screener results.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Beauty Farm Medical and Health Industry Inc. operates in the beauty and health sector, with a market cap of HK$4.84 billion.
Operations: The company's revenue is derived from several segments, including Aesthetic Medical Services (CN¥1.02 billion), Subhealth Medical Services (CN¥325.92 million), Beauty and Wellness Services - Direct Stores (CN¥1.51 billion), and Beauty and Wellness Services - Franchisee and Others (CN¥145.67 million).
Insider Ownership: 32.2%
Revenue Growth Forecast: 15.1% p.a.
Beauty Farm Medical and Health Industry is experiencing robust growth with earnings rising 39% last year and forecasted to grow at 22.05% per annum, outpacing the Hong Kong market. Insiders have shown confidence through net buying activity recently, albeit in modest volumes. The company trades significantly below its estimated fair value, suggesting potential undervaluation. Recent acquisitions like Siyanli are enhancing market share and profitability, while internal growth initiatives boost revenue and operational efficiency across its beauty and wellness segments.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Linklogis Inc. is an investment holding company that offers supply chain finance technology and data-driven solutions in China and internationally, with a market cap of HK$3.70 billion.
Operations: The company's revenue segments include CN¥546 million from Anchor Cloud and CN¥384.20 million from FI Cloud under Supply Chain Finance Technology Solutions, along with CN¥52.55 million from Emerging Solutions - Cross-Border Cloud.
Insider Ownership: 25.5%
Revenue Growth Forecast: 17.4% p.a.
Linklogis is poised for significant growth, with earnings projected to increase by 148.93% annually and revenue expected to rise at 17.4% per year, surpassing the Hong Kong market average. Despite a recent CFO transition, the appointment of Mr. Huang Weibo brings extensive financial expertise to the role. The company declared a special dividend of HK$0.06 per share, reflecting confidence in its financial health amid high insider ownership and no substantial insider trading activity recently observed.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Willfar Information Technology Co., Ltd. offers smart utility services and IoT solutions both in China and internationally, with a market cap of CN¥14.11 billion.
Operations: The company's revenue segments include smart utility services and IoT solutions, both domestically and internationally.
Insider Ownership: 19.4%
Revenue Growth Forecast: 18.5% p.a.
Willfar Information Technology demonstrates potential for growth, with earnings projected to grow significantly at 20.52% annually, although slower than the Chinese market average. The company is trading at a favorable price-to-earnings ratio of 20.9x compared to the broader CN market's 38.8x, indicating good value relative to peers. Recent completion of a CNY 50 million share buyback plan underscores confidence in its financial stability and supports insider ownership without substantial recent insider trading activity noted.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com